+1,619.1%
GSK vs VICR
+9,228.3%
-7,609.2%
-55.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | VICR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.3% | -1.1% | -1.3% | -2.3% |
| 7D | -3.0% | -10.3% | +7.3% | -2.3% |
| 30D | +0.4% | -24.3% | +24.6% | +1.7% |
| 3M | -1.2% | -42.8% | +41.6% | +1.3% |
| 6M | +0.9% | -47.0% | +48.0% | +2.7% |
| YTD | +4.0% | +32.3% | -28.3% | -2.4% |
| 1Y | +7.3% | +66.5% | -59.2% | -1.1% |
| 3Y | +57.1% | +269.4% | -212.3% | +31.3% |
| 5Y | +43.0% | -11.0% | +54.0% | +28.0% |
| 10Y | +103.1% | +882.8% | -779.8% | +39.6% |
| All | +1,619.1% | +9,228.3% | -7,609.2% | +613.8% |
Cumulative growth
Daily Returns
Daily percentage return beside VICR.
Daily Out/Under-Performance
Portfolio return minus VICR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VICR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded VICR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling